UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study

Journal of hepatology, 2007-10, Vol.47 (4), p.499-505

2007

Volltextzugriff (PDF)

P.01.4 LEVODOPA ENTERAL INFUSION (DUODOPA®) THROUGH PERMANENT PERCUTANEOUS ENDOSCOPIC GASTROSTOMY IN PATIENTS WITH ADVANCED PARKINSON'S DISEASE: SAFETY AND TOLERABILITY OF THE ENDOSCOPIC PROCEDURE

Digestive and liver disease, 2012-03, Vol.44, p.S90-S90

2012

Volltextzugriff (PDF)

P.1.282: LEVODOPA ENTERAL INFUSION (DUODOPA®) THROUGH PERMANENT PERCUTANEOUS ENDOSCOPIC GASTROSTOMY IN PATIENTS WITH ADVANCED PARKINSON'S DISEASE: THE EXPERIENCE OF A SECONDARY LEVEL HOSPITAL

Digestive and liver disease, 2011, Vol.43, p.S242-S242

2011

Volltextzugriff (PDF)

Hepatic involvement in larva migrans of Toxocara canis: Report of a case with pathological and radiological findings

Digestive and liver disease, 2006-07, Vol.38 (7), p.511-514

2006

Volltextzugriff (PDF)

Percutaneous endoscopic gastrostomy: A long-term follow-up

Nutrition (Burbank, Los Angeles County, Calif.), 1997-06, Vol.13 (6), p.520-523

1997

Volltextzugriff (PDF)

[216] MIDODRINE IN THE PREVENTION OF HEPATORENAL SYNDROME TYPE 2 RECURRENCE: A CASE-CONTROL STUDY

Journal of hepatology, 2007, Vol.46, p.S89-S90

2007

Volltextzugriff (PDF)

270 LOW VS STANDARD ALBUMIN DOSAGES IN THE PREVENTION OF PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION: A PRELIMINARY ANALYSIS

Journal of hepatology, 2008, Vol.48, p.S109-S109

2008

Volltextzugriff (PDF)

Multicentre randomized placebo‐controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis

Alimentary pharmacology & therapeutics, 2000-12, Vol.14 (12), p.1645-1652

2000

Volltextzugriff (PDF)

Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver‐kidney microsomes

Hepatology (Baltimore, Md.), 1995-11, Vol.22 (5), p.1374-1378

1995

Volltextzugriff (PDF)

Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM): Clinical characterization from idiopathic LKM-positive disorders

Journal of hepatology, 1991-07, Vol.13 (1), p.128-131

1991

Volltextzugriff (PDF)

Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal

The American journal of gastroenterology, 2002-09, Vol.97 (9), p.2383-2390

2002

Volltextzugriff (PDF)

Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal

The American journal of gastroenterology, 2002-09, Vol.97 (9), p.2383-2390

2002

Volltextzugriff (PDF)

Lymphocytic gastritis and protein-losing gastropathy

Digestive and liver disease, 2000-06, Vol.32 (5), p.422-425

2000

Volltextzugriff (PDF)

Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes

Hepatology (Baltimore, Md.), 1995, Vol.22 (5), p.1374-1378

1995

Volltextzugriff (PDF)

Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis

Journal of hepatology, 2004-03, Vol.40 (3), p.417-423

2004

Volltextzugriff (PDF)

Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: comparison with propranolol in a randomised controlled study

Journal of hepatology, 2003-04, Vol.38 (4), p.455-460

2003

Volltextzugriff (PDF)

Admission to a gastroenterology unit for adverse drug reactions

Digestive and liver disease, 2006-04, Vol.38, p.S219-S220

2006

Volltextzugriff (PDF)

203 Noradrenaline vs terlipressin in hepatorenal syndrome: A prospective, randomized study

Journal of hepatology, 2006-04, Vol.44, p.S83-S84

2006

Volltextzugriff (PDF)

197 Inappropriately low angiotensin-converting enzyme (ACE) plasma levels: A factor worsening kidney function and survival rate in subsets of patients with decompensated cirrhosis

Journal of hepatology, 2004, Vol.40, p.64-64

2004

Volltextzugriff (PDF)

Efficacy of irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertension

Digestive diseases and sciences, 2002-02, Vol.47 (2), p.401-404

2002

Volltextzugriff (PDF)

Endoscopic measurement of variceal pressure in patients with portal hypertension: Correlation with portal pressure

Digestive and liver disease, 2006-04, Vol.38, p.S90-S91

2006

Volltextzugriff (PDF)

219 Angiotensin II type 1 receptor inhibition in early stage cirrhotic patients: Effects on portal pressure and liver fibrosis

Journal of hepatology, 2004, Vol.40, p.70-70

2004

Volltextzugriff (PDF)

17 Inappropriately low angiotensin II production: A factor determining impaired renal function and reduced survival in patients with decompensated liver cirrhosis

Digestive and liver disease, 2003-02, Vol.35, p.A7-A7

2003

Volltextzugriff (PDF)

Loss of tubular-glomerular feedback as a further mechanism of sodiumretention during posture in preascitic liver cirrhosis

Journal of hepatology, 2000, Vol.32, p.65-65

2000

Volltextzugriff (PDF)

Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: Comparison with propranolol in a randomised controlled study

Digestive and liver disease, 2001-11, Vol.33, p.A22-A22

2001

Volltextzugriff (PDF)

1 – 25 von 176

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(135)

Publikationsform

Artikel
(174)
Tagungsberichte
(2)

Sprache

Englisch
(164)
Italienisch
(12)

Erscheinungsjahr

n.n

Thema

Humans
(124)
Science & Technology
(119)
Female
(116)
Life Sciences & Biomedicine
(112)
Pregnancy
(103)
Obstetrics & Gynecology
(58)
Adult
(56)
Biological And Medical Sciences
(38)
Medical Sciences
(32)
Growth Charts
(28)
Male
(28)
Fetal Development
(27)
Gestational Age
(27)
Obstetrics
(25)
Infant, Newborn
(24)
Ultrasonography, Prenatal
(23)
Child Development
(21)
Fetal Growth
(21)
Multicenter Studies As Topic - Methods
(21)
Technology
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study

P.01.4 LEVODOPA ENTERAL INFUSION (DUODOPA®) THROUGH PERMANENT PERCUTANEOUS ENDOSCOPIC GASTROSTOMY IN PATIENTS WITH ADVANCED PARKINSON'S DISEASE: SAFETY AND TOLERABILITY OF THE ENDOSCOPIC PROCEDURE

P.1.282: LEVODOPA ENTERAL INFUSION (DUODOPA®) THROUGH PERMANENT PERCUTANEOUS ENDOSCOPIC GASTROSTOMY IN PATIENTS WITH ADVANCED PARKINSON'S DISEASE: THE EXPERIENCE OF A SECONDARY LEVEL HOSPITAL

Hepatic involvement in larva migrans of Toxocara canis: Report of a case with pathological and radiological findings

Percutaneous endoscopic gastrostomy: A long-term follow-up

[216] MIDODRINE IN THE PREVENTION OF HEPATORENAL SYNDROME TYPE 2 RECURRENCE: A CASE-CONTROL STUDY

270 LOW VS STANDARD ALBUMIN DOSAGES IN THE PREVENTION OF PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION: A PRELIMINARY ANALYSIS

Multicentre randomized placebo‐controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis

Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver‐kidney microsomes

Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM): Clinical characterization from idiopathic LKM-positive disorders

Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal

Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal

Lymphocytic gastritis and protein-losing gastropathy

Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes

Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis

Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: comparison with propranolol in a randomised controlled study

Admission to a gastroenterology unit for adverse drug reactions

203 Noradrenaline vs terlipressin in hepatorenal syndrome: A prospective, randomized study

197 Inappropriately low angiotensin-converting enzyme (ACE) plasma levels: A factor worsening kidney function and survival rate in subsets of patients with decompensated cirrhosis

Efficacy of irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertension

Endoscopic measurement of variceal pressure in patients with portal hypertension: Correlation with portal pressure

219 Angiotensin II type 1 receptor inhibition in early stage cirrhotic patients: Effects on portal pressure and liver fibrosis

17 Inappropriately low angiotensin II production: A factor determining impaired renal function and reduced survival in patients with decompensated liver cirrhosis

Loss of tubular-glomerular feedback as a further mechanism of sodiumretention during posture in preascitic liver cirrhosis

Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: Comparison with propranolol in a randomised controlled study

Suchergebnisse filtern